Article
Both R5 and X4 human immunodeficiency virus type 1 variants persist during prolonged therapy with five antiretroviral drugs.
Journal of virology - 1 Mar 2002
van Rij Ronald P, Visser Janny A, van Praag Rieneke M E, Rientsma Ronald, Prins Jan M, Lange Joep M A, Schuitemaker Hanneke
Abstract excerpt
A viral reservoir of human immunodeficiency virus type 1 (HIV-1)-infected, resting CD4(+) T cells persists despite suppression of plasma viremia by combination antiretroviral therapy. In a longitudinal analysis of three patients treated with a five-drug regimen, both R5 and X4 HIV-1 variants persisted in the cellular reservoir for up to 3 years.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
